期刊文献+

淋巴毒素α多态性位点与中国汉族非心源性缺血性卒中的关联研究

Association Studies on Lymphotoxin-α Polymorphisms and Noncardiogenic Ischemic Stroke in Chinese Han Population
下载PDF
导出
摘要 目的在中国汉族人群中研究淋巴毒素α(lymphotoxinα,LTA)基因多态性位点是否为非心源性缺血性卒中的危险因素。方法采用Taqman-MGB探针法在558名非心源性缺血性卒中患者和557名健康成人中对LTA的rs1800683、rs909253、rs1041981三个多态性位点进行基因分型。在单核苷酸多态性水平和单体型水平进行关联分析,并使用Bonferroni法进行多重检验校正。结果 LTA的三个单核甘酸多态性的不同等位基因和基因型在非心源性缺血性卒中组和对照组分布未见统计学差异。以最常见的单体型AGA作为参照,在校正传统危险因素后,GGC携带者有0.381倍卒中发病风险(95%CI:0.198~0.733,P=0.003)。结论 GGC单体型可能是非心源性缺血性卒中发病的保护性因素,有待于在前瞻性研究中进一步证实。 Objective The aim of the present study was to explore whether genetic polymorphisms of lymphotoxin-alpha (LTA) gene are risk factors for noncardiogenic ischemic stroke in Han Chinese population. Methods Three common variants of LTA, rs1800683, rs909253 and rs1041981, were genotyped in a sample including 558 noncardiogenic ischemic stroke cases and 557 normal controls using Taqman-MGB assay in a case-control study. The association analyses were performed at both single nucleotide polymorphism and haplotype levels. Bonferroni correction was applied for multiple corrections. Results No significant association were found between any of these LTA alleles or genotypes with risk ofnoncardiogenic ischemic stroke. When AGA haplotype was chosen as the baseline for adjusting conventional risk factors, the protective effect for haplotype GGC remained significant (AGA versus GGC; OR, 0.381; 95%CI, 0.198 to 0.733; P=0.003). Conclusion The GGC haplotype of LTA maybe a protective factor in pathogenesis of noncardiogenic ischemic stroke warrants further confirm in a prospective study.
出处 《中国卒中杂志》 2010年第12期962-966,共5页 Chinese Journal of Stroke
基金 国家863计划资助项目(2006AA02A406)
关键词 脑梗死 淋巴毒素Α 多态性 单核甘酸 Brain infarction lymphotoxin-alpha Polymorphism, single nucleotide
  • 相关文献

参考文献24

  • 1Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. The World Health Organization MONICA Project[J]. nt J Epidemiol, 1994, 23:505-516.
  • 2He J, Klag M J, Wu Z, et al. Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors[J]. Stroke, 1995, 26:2222-2227.
  • 3Elder S J, Lichtenstein AH, Pittas AG, et al. Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome[J]. J Lipid Res, 2009, 50:1917-1926.
  • 4Kuiper J, van Puijvelde GH, van Wanrooij E J, et al Immunomodulation of the inflammatory response in atherosclerosis[J]. Curr Opin Lipidol, 2007 18:521-526.
  • 5Ross R. Atherosclerosis is an inflammatory disease[J]. Am Heart J, 1999 138(5 Pt 2):$419-420.
  • 6Schneider K, Potter KG, Ware CF. Lymphotoxin and LIGHT signaling pathways and target genes[J]. lmmunol Rev, 2004, 202:49-66.
  • 7Ware CF. Network communications:lymphotoxins, LIGHT, and TNF[J]. Annu Rev lmmunol, 2005, 23:787-819.
  • 8Cavender DE, Edelbaum D, Ziff M. Endothelial cell activation induced by tumor necrosis factor and lymphotoxin[J]. Am J Pathol, 1989, 134:551-560.
  • 9Pober JS, Lapierre LA, Stolpen AH, et al. Activation of cultured human endothelial cells by recombinant lymphotoxin:comparison with tumor necrosis factor and interleukin 1 species[J]. J Immunol, 1987 138:3319-3324.
  • 10Schreyer SA, Vick CM, LeBoeuf RC. Loss of lymphotoxin-alpha but not tumor necrosis factor-alpha reduces atherosclerosis in mice[J]. J Biol Chem, 2002, 277:12364-12368.

二级参考文献16

  • 1[1]Adams H,Bendixen B. Classification subtype of acute ischemic stroke. Definitions for use in a muticenter clinical trial.TOAST. Of Org 10 172 in Acute[J]. Stroke, 1993,24:35-41.
  • 2[2]Madden K,Adams H. Accuracy of initial stroke subtype diagnosis in the TOAST study [J]. Neurology, 1995,45 ( 11 ):1 975-1 979.
  • 3[3]Lee L, Kidwell C. Impact on Stroke Subtype Diagnosis of Early Diffusion-Weighted Magnetic Resonance Imaging and Magnetic Resonance Angiography [J]. Stroke, 2000, 31 ( 5 ):1 081-1 089.
  • 4[4]Petty G, Brown R. Ischemic Stroke Subtypes: A PopulationBased Study of Incidence and Risk Factors[J]. Stroke, 1999,30(12) :2 513-2 516.
  • 5[5]Woo D, Gebel, J. Incidence Rates of First-Ever Ischemic Stroke Subtypes Among Blacks: A Population-Based Study[J]. Stroke,1999,30(12):2 517-2 522.
  • 6[6]Hassaballa H, Gorelick P. Ischemic stroke outcome: Racial differences in the trial of danaparoid in acute stroke (TOAST)[J]. Neurology, 2001,57(4) :691-697.
  • 7[7]Kolominsky-Rabas, Peter L, Weber M. Epidemiology of Ischemic Stroke Subtypes According to TOAST Criteria: Incidence, Recurrence, and Long- Term Survival in Ischemic Stroke Subtypes: A Population- Based Study [J]. Stroke,2001,32(12):2 735-2 740.
  • 8[8]Lopez F, Aladro B. Acute cerebral ischemia in patients under 45 years of age: a study in a series of 68 patients[J]. RevNeurol, 1998,27:640- 644.
  • 9[9]Saposnik G, Caplan L. Differences in Stroke Subtypes Among Natives and Caucasians in Boston and Buenos Aires [J].Stroke, 2000, 31(10) :2 385-2 389.
  • 10[10]Jeng J,Chung M. Extracranial carotid artery atherosclerosis and vascular risk factors in different types of ischemic stroke in Taiwan[J]. Stroke, 1994,25:1 989 - 1 993.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部